205 results on '"Broderick, Stephen R."'
Search Results
2. The Society of Thoracic Surgeons 2024 Risk Models for Lung Cancer Resection: Continued Refinement and Improved Outcomes
3. Variability in Smoking Status for Lobectomy Among Society of Thoracic Surgeons Database Participants
4. Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab
5. Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy
6. Elevated neutrophil to lymphocyte ratio is associated with poor long-term survival and graft failure after lung transplantation
7. Adjuvant and Neoadjuvant Immunotherapy in Non–small Cell Lung Cancer
8. The Society of Thoracic Surgeons Composite Score Rating for Pulmonary Resection for Lung Cancer
9. Epigenetic therapy inhibits metastases by disrupting premetastatic niches
10. Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study
11. Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer
12. Sarcopenia of the Psoas Muscles Is Associated With Poor Outcomes Following Lung Transplantation
13. Defining Proficiency for The Society of Thoracic Surgeons Participants Performing Thoracoscopic Lobectomy
14. Traumatically Brain-Injured Donors and the Impact on Lung Transplantation Survival
15. Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab
16. Impaired Renal Function Should Not Be a Barrier to Transplantation in Patients With Cystic Fibrosis
17. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy
18. Adjuvant Therapy for Positive Nodes After Induction Therapy and Resection of Esophageal Cancer
19. Figure S2 from Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer
20. Commentary: Are we at a CROSSroads in neoadjuvant therapy for esophageal cancer?
21. Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy
22. Unexpected readmission after lung cancer surgery: A benign event?
23. Does surgeon experience affect outcomes in pathologic stage I lung cancer?
24. Intraoperative conversion from video-assisted thoracoscopic surgery lobectomy to open thoracotomy: A study of causes and implications
25. Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non–small-cell lung cancer
26. Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer
27. Commentary: Perioperative systemic therapy in early-stage non–small cell lung cancer: The future is bright
28. Management of Barrett’s Esophagus
29. Bivalirudin and Venoarterial Extracorporeal Membrane Oxygenation for Treatment of Massive Pulmonary Embolism From Heparin-Induced Thrombocytopenia With Thrombosis
30. Performance of Integrated Positron Emission Tomography/Computed Tomography for Mediastinal Nodal Staging in Non-Small Cell Lung Carcinoma
31. Hemothorax: Etiology, Diagnosis, and Management
32. Neuroendocrine tumors of the lung: Has the stage been set?
33. PET Staging of Mediastinal Lymph Nodes in Thoracic Oncology
34. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
35. When in doubt … ask the patient: Patient-reported measures and prognosis in esophageal cancer
36. Bivalirudin and Venoarterial Extracorporeal Membrane Oxygenation for Treatment of Massive Pulmonary Embolism From Heparin-Induced Thrombocytopenia With Thrombosis.
37. SCCRO Promotes Glioma Formation and Malignant Progression in Mice
38. The Society of Thoracic Surgeons General Thoracic Surgery Database: 2021 Update on Outcomes and Research
39. Commentary: Reducing Resection of Benign Pulmonary Nodules – A Laudable Goal, but How and at What Cost?
40. Lobectomy versus stereotactic body radiotherapy for stage I non–small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?
41. The Society of Thoracic Surgeons General Thoracic Surgery Database: 2020 Update on Outcomes and Research
42. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network
43. Commentary: Defining HSR: Health services research or healthy skepticism remains
44. The Society of Thoracic Surgeons General Thoracic Surgery Database 2019 Update on Outcomes and Quality
45. Perioperative considerations for neoadjuvant immunotherapy in non–small cell lung cancer
46. COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network
47. Commentary: Chemo if you can—disparities in receipt of guideline-concordant adjuvant therapy in patients with locoregional non–small cell lung cancer
48. Invited Commentary
49. Contributors
50. Saturation simulation of mass EV charging on congested 230 V LV networks
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.